Revance Therapeutics Inc logo

Revance Therapeutics Inc

FRA:RTI (USA)  
€ 2.94 (0%) Dec 27
At Loss
Market Cap:
€ 306.50M ($ 319.64M)
Enterprise V:
€ 593.75M ($ 619.20M)
Volume:
-
Avg Vol (2M):
1.24K
Trade In:

Revance Therapeutics Inc Valuation Measures